| Correlation of humoral immune responses to different SARS-CoV-2 antigens with virus neutralizing antibodies and symptomatic severity in a German COVID-19 cohort A Rockstroh, J Wolf, J Fertey, S Kalbitz, S Schroth, C Lübbert, S Ulbert, ... Emerging microbes & infections 10 (1), 774-781, 2021 | 44 | 2021 |
| A urinary peptidomic profile predicts outcome in SARS-CoV-2-infected patients R Wendt, L Thijs, S Kalbitz, H Mischak, J Siwy, J Raad, J Metzger, ... EClinicalMedicine 36, 2021 | 33 | 2021 |
| Urinary peptides significantly associate with COVID‐19 severity: pilot proof‐of‐principle data and design of a multicentric diagnostic study R Wendt, S Kalbitz, C Lübbert, N Kellner, M Macholz, S Schroth, ... Proteomics 20 (24), 2000202, 2020 | 29 | 2020 |
| Evaluation of the systemic and mucosal immune response induced by COVID-19 and the BNT162b2 mRNA vaccine for SARS-CoV-2 O Nickel, A Rockstroh, J Wolf, S Landgraf, S Kalbitz, N Kellner, M Borte, ... PLoS one 17 (10), e0263861, 2022 | 22 | 2022 |
| Assessment of the effect of iris colour and having children on 5-year risk of death after diagnosis of uveal melanoma: a follow-up study A Schmidt-Pokrzywniak, S Kalbitz, O Kuss, KH Jöckel, N Bornfeld, ... BMC ophthalmology 14, 1-8, 2014 | 22 | 2014 |
| Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection: a prospective multicentre cohort study JA Staessen, R Wendt, YL Yu, S Kalbitz, L Thijs, J Siwy, J Raad, ... The Lancet Digital Health 4 (10), e727-e737, 2022 | 20 | 2022 |
| Differences of SARS-CoV-2 serological test performance between hospitalized and outpatient COVID-19 cases J Wolf, T Kaiser, S Pehnke, O Nickel, C Luebbert, S Kalbitz, B Arnold, ... Clinica chimica acta 511, 352-359, 2020 | 19 | 2020 |
| Generalized cowpox virus infection in an immunosuppressed patient R Wendt, J Tittelbach, L Schrick, N Kellner, S Kalbitz, B Ruehe, J Michel, ... International Journal of Infectious Diseases 106, 276-278, 2021 | 18 | 2021 |
| CD99 and polymeric immunoglobulin receptor peptides deregulation in critical COVID‐19: A potential link to molecular pathophysiology? J Siwy, R Wendt, A Albalat, T He, H Mischak, W Mullen, A Latosinska, ... Proteomics 21 (20), 2100133, 2021 | 17 | 2021 |
| Clinical outcomes of hospitalized COVID-19 patients treated with remdesivir: a retrospective analysis of a large tertiary care center in Germany K Marx, K Gončarova, D Fedders, S Kalbitz, N Kellner, M Fedders, ... Infection 51 (1), 97-108, 2023 | 13 | 2023 |
| Clinical relevance of elevated soluble ST2, HSP27 and 20S proteasome at hospital admission in patients with COVID-19 R Wendt, MT Lingitz, M Laggner, M Mildner, D Traxler, A Graf, P Krotka, ... Biology 10 (11), 1186, 2021 | 13 | 2021 |
| Comprehensive investigation of an in-hospital transmission cluster of a symptomatic SARS-CoV-2–positive physician among patients and healthcare workers in Germany R Wendt, S Nagel, O Nickel, J Wolf, S Kalbitz, T Kaiser, S Borte, C Lübbert Infection Control & Hospital Epidemiology 41 (10), 1209-1211, 2020 | 4 | 2020 |
| Unhappy Triad: Infection with Leptospira spp. Escherichia coli and Bacteroides uniformis Associated with an Unusual Manifestation of Portal Vein Thrombosis S Kalbitz, J Ermisch, JM Schmidt, I Wallstabe, C Lübbert Case Reports in Gastroenterology 15 (2), 598-602, 2021 | 3 | 2021 |
| Diagnosis of Hereditary TTP Caused by Homozygosity for a Rare Complex ADAMTS13 Allele After Salmonella Infection in a 43-Year-Old Asylum Seeker R Wendt, S Kalbitz, F Otto, T Falter, J Beige, H Rossmann, B Lämmle Frontiers in Medicine 8, 639441, 2021 | 2 | 2021 |
| Survival after cryptococcosis in Germany: A retrospective multicenter cohort study of patients diagnosed between 2004 and 2021 J Kessel, AC Rossaert, T Lingscheid, J Grothe, T Harrer, C Wyen, ... International Journal of Medical Microbiology 314, 151614, 2024 | 1 | 2024 |
| COVID-19 treatment strategies with drugs centrally procured by the German Federal Ministry of Health in a representative tertiary care hospital: a temporal analysis K Marx, S Kalbitz, N Kellner, M Fedders, C Lübbert GMS Infectious Diseases 11, 2023 | 1 | 2023 |
| Erkrankungen durch hochpathogene Erreger–Teil 1 S Kalbitz, N Kellner, M Macholz, J Ermisch, J Fechner, C Lübbert Krankenhaushygiene up2date 17 (04), 371-390, 2022 | 1 | 2022 |
| Clinical relevance of elevated soluble ST2, HSP27 and 20S proteasome in patients with COVID-19 R Wendt, MT Lingitz, M Laggner, M Mildner, D Traxler, A Graf, P Krotka, ... Preprints, 2021 | 1 | 2021 |
| Comparative Analysis of Lymphocyte Populations in Post-COVID-19 Condition and COVID-19 Convalescent Individuals L Berger, J Wolf, S Kalbitz, N Kellner, C Lübbert, S Borte Diagnostics 14 (12), 1286, 2024 | | 2024 |
| Metagenomic next-generation sequencing as a diagnostic tool in the clinical routine of an infectious diseases department: a retrospective cohort study S Kalbitz, J Ermisch, N Kellner, O Nickel, S Borte, K Marx, C Lübbert Infection, 1-6, 2024 | | 2024 |
